1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: Clinical and immunologic analyses from the randomized phase 2 PRINCE trial
    Journal Article

    Padrón, L. J.; Maurer, D. M.; O’Hara, M. H.; O’Reilly, E. M.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G.; Rahma, O.; Lyman, J. P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: Final results from the BFORE trial
    Journal Article

    Brümmendorf, T. H.; Cortes, J. E.; Milojkovic, D.; Gambacorti-Passerini, C.; Clark, R. E.; le Coutre, P.; Garcia-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): Long-term follow-up results from an open-label, randomised, phase 3 trial
    Journal Article

    Motzer, R. J.; Powles, T.; Burotto, M.; Escudier, B.; Bourlon, M. T.; Shah, A. Y.; Suárez, C.; Hamzaj, A.; Porta, C.; Hocking, C. M.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Results from 22 years of followup in the Göteborg randomized population-based prostate cancer screening trial
    Journal Article

    Frånlund, M.; Månsson, M.; Godtman, R. A.; Aus, G.; Holmberg, E.; Kollberg, K. S.; Lodding, P.; Pihl, C. G.; Stranne, J.; Lilja, H.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Children's Oncology Group Trial AALL1231: A phase III clinical trial testing bortezomib in newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma
    Journal Article

    Teachey, D. T.; Devidas, M.; Wood, B. L.; Chen, Z.; Hayashi, R. J.; Hermiston, M. L.; Annett, R. D.; Archer, J. H.; Asselin, B. L.; August, K. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: A randomized clinical trial
    Journal Article

    Basch, E.; Schrag, D.; Henson, S.; Jansen, J.; Ginos, B.; Stover, A. M.; Carr, P.; Spears, P. A.; Jonsson, M.; Deal, A. M.; more...
    JAMA - Journal of the American Medical Association (2022)

    Fulltext@MSK | Save
  • Effects of vigorous versus restorative yoga practice on objective cognition functions in sedentary breast and ovarian cancer survivors: A randomized controlled pilot trial
    Journal Article

    Deng, G.; Bao, T.; Ryan, E. L.; Benusis, L.; Hogan, P.; Li, Q. S.; Dries, A.; Konner, J.; Ahles, T. A.; Mao, J. J.
    Integrative Cancer Therapies (2022)

    Fulltext@MSK | Save
  • A randomized phase II study of MEDI0680 in combination with durvalumab versus nivolumab monotherapy in patients with advanced or metastatic clear-cell renal cell carcinoma
    Journal Article

    Voss, M. H.; Azad, A. A.; Hansen, A. R.; Gray, J. E.; Welsh, S. J.; Song, X.; Kuziora, M.; Meinecke, L.; Blando, J.; Achour, I.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]
    Journal Article

    Goshe, B. M.; Rasmussen, A. W.; Wagner, L. I.; Sicks, J. R. D.; Gareen, I. F.; Carlos, R. C.; Herman, B. A.; Walter, A. W.; Regan, S.; Levy, D. E.; more...
    BMC Public Health (2022)

    Fulltext@MSK | Save
  • Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: Updated results of the E1912 trial
    Journal Article

    Shanafelt, T. D.; Wang, X. V.; Hanson, C. A.; Paietta, E. M.; O'Brien, S.; Barrientos, J.; Jelinek, D. F.; Braggio, E.; Leis, J. F.; Zhang, C. C.; more...
    Blood (2022)

    Fulltext@MSK | Save